HINOON financials Highnoon Laboratories Limited
Highnoon Laboratories Limited (HINOON) has 13 financial years on file, from the year to 31 Dec 2011. The latest, the year to 31 Dec 2025 earned Rs 77.75 a share on sales of Rs 25.8 bn. 5 quarters are listed below the years.
Results by financial year
Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 31 December. 4 of the last 5 years and 5 of the last 8 quarters.
Earnings per share by financial year
| Year | Earnings per share (Rs) | Sales | Gross margin | Net profit as a share of sales | Change in earnings per share on the year before |
|---|---|---|---|---|---|
| Year to 31 Dec 2025 | 77.75 | Rs 25.8 bn | 54.8% | 16.0% | +26.6% |
| Year to 31 Dec 2024 | 61.41 | Rs 23.2 bn | 51.4% | 14.0% | +35.4% |
| Year to 31 Dec 2023 | 45.35 | Rs 19.4 bn | 47.6% | 12.4% | -0.6% |
| Year to 31 Dec 2022 | 45.62 | Rs 15.8 bn | 50.8% | 15.3% | — |
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 17.81 | Rs 6.6 bn | Rs 943.6 m | 14.3% | -5.7% |
| Quarter to 30 Jun 2026 | 13.62 | Rs 5.9 bn | Rs 721.8 m | 12.3% | +1.4% |
| Quarter to 31 Mar 2026 | 18.04 | Rs 6.8 bn | Rs 955.7 m | 14.0% | — |
| Quarter to 30 Sep 2025 | 18.89 | Rs 6.6 bn | Rs 1.0 bn | 15.2% | — |
| Quarter to 30 Jun 2025 | 13.43 | Rs 5.5 bn | Rs 711.7 m | 13.0% | — |
Annual report figures: income and balance sheet
From each annual report. A blank is a line this page does not show for that year.
| Year | Revenue | Gross profit | Profit after tax | Total assets | Equity | Liabilities | Return on equity | Current ratio | Basis |
|---|---|---|---|---|---|---|---|---|---|
| Year to 31 Dec 2025 | — | — | — | Rs 18.4 bn | Rs 13.2 bn | — | — | 3.06 | unknown |
| Year to 31 Dec 2023 | — | — | — | Rs 14.7 bn | — | — | — | — | consolidated |
| Year to 31 Dec 2022 | — | — | — | Rs 10.6 bn | Rs 7.4 bn | Rs 3.2 bn | — | 3.37 | unknown |
| Year to 31 Dec 2020 | — | — | — | Rs 6.6 bn | Rs 4.1 bn | Rs 2.6 bn | — | 2.85 | unknown |
| Year to 31 Dec 2019 | — | — | — | Rs 4.6 bn | Rs 2.8 bn | Rs 1.8 bn | — | 2.51 | unknown |
| Year to 31 Dec 2018 | — | — | — | Rs 3.8 bn | Rs 2.6 bn | Rs 1.1 bn | — | 3.75 | unknown |
| Year to 31 Dec 2017 | — | — | — | Rs 3.4 bn | Rs 2.5 bn | Rs 861.1 m | — | 5.01 | unknown |
| Year to 31 Dec 2015 | — | — | — | Rs 2.3 bn | — | — | — | — | unknown |
| Year to 31 Dec 2014 | — | — | — | Rs 1.9 bn | — | — | — | — | unknown |
| Year to 31 Dec 2013 | — | — | — | Rs 1.6 bn | — | — | — | — | unknown |
| Year to 31 Dec 2012 | — | — | — | Rs 1.7 bn | — | — | — | — | unknown |
| Year to 31 Dec 2011 | — | — | — | Rs 1.6 bn | — | — | — | — | unknown |
Source: annual report, page 161.
Ratios from the latest annual report
- Book value a share
- Rs 248.57
- Price to book value
- 3.86 times
- Current ratio
- 3.06
- Debt to equity
- 0.40
- Equity as a share of assets
- 71.5%
As of 31 Dec 2025.
Debt
Borrowings and cash
- Cash
- Rs 468.8 m
Company accounts, year to 31 Dec 2025 · filed annual report, page 174
More on HINOON
- HINOON share price and overview
- HINOON dividend history
- Pharmaceuticals sector
- HPL financials · Hoechst Pakistan Limited
- IBLHL financials · IBL HealthCare Limited
- LIVEN financials · Liven Pharma Limited
- GLAXO financials · GlaxoSmithKline Pakistan Limited
- ABOT financials · Abbott Laboratories (Pakistan) Limited
- HALEON financials · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .